Data in the literature show that the expression of Mtus1 is down-regulated in a wide range of cancers: colon tumors, breast cancer, ovarian cancer, head and neck squamous cell carcinoma, as well as prostate cancer cell lines [47–50]. Here, MTUS1 is linked to prostate cancer.